Home
About Us
Structure
Current Events
Past Events
Video Gallery
Policy & Reports
Awards
Membership
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
Video Gallery
15th Annual BioPharma & Healthcare Summit, June 22, 2021 - Virtual Edition
  • Welcome address by Karun Rishi, President, USAIC

    Welcome address: Karun Rishi, President, USAIC

  • Opening comments by Dr Andrew Plump

    Opening comments: Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals

  • Fireside Chat with Dr. Albert Bourla moderated by Dr. Stelios Papadopoulos

    Dr. Albert Bourla, Chairman & CEO, Pfizer
    Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

  • Fireside Chat with Dr. Janet Woodcock moderated by Dr. William Chin

    Dr. Janet Woodcock, Acting Commissioner, U.S. Food and Drug Administration
    Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

  • R&D Strategies & Trends Panel

    Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals, Dr. David Reese, Executive Vice President, Research and Development, Amgen, Dr. John Reed, Global Head of R&D, Sanofi, Dr. Mathai Mammen, Global Head of Janssen R&D, Johnson & Johnson
    Moderator: Dr. Martin Mackay, Co-Founder, Rallybio

  • India Innovation Panel

    Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India, Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries Limited, Prof. K. Vijay Raghavan, Principal Scientific Advisor, Government of India, Dr. Naresh Trehan, Chairman, Medanta Hospital
    Moderator: Sanat Chattopadhyay, President- Merck Manufacturing Division, Merck & Co.

  • Fireside Chat: Robert Bradway moderated by Kiran Mazumdar-Shaw

    Fireside Chat: Robert Bradway, Chairman & CEO, Amgen
    Moderator: Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

  • Fireside Chat with Dr. Francis Collins moderated by Dr. Elias Zerhouni

    Fireside Chat: Dr. Francis Collins, Director, National Institutes of Health, Dr. Margaret Hamburg, Former Commissioner, U.S. Food and Drug Administration
    Moderator: Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University

  • Oncology Panel

    Panelists: Dr. Bruce Chabner, Director of Clinical Research, Massachusetts General Hospital Cancer Center, Dr. Carrie Brownstein, Chief Medical Officer, Cellectis, Dr. Philip Larsen, Global Head of Research, Bayer AG, Dr. Sam Waksal, Founder, MeiraGTx, Vivek Ramaswamy, Founder & Executive Chairman, Roivant Sciences
    Moderator: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic

  • Industry & Investment Outlook Panel

    Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital, Dr. Peter Orszag, Chief Executive Officer - Financial Advisory, Lazard Freres, Rajiv Kaul, Portfolio Manager, Fidelity Investments, Dr. Stelios Papadopoulos, Chairman, Biogen
    Moderator: Daphne Zohar, Co-Founder and Chief Executive Officer, PureTech Health

  • Digital & Data Science Panel

    Panelists: Craig Kennedy, Senior Vice President, Merck & Co., Dr. Daphne Koller, Founder & CEO, insitro, Dr. Karen Akinsanya, Chief Biomedical Scientist, Schrödinger, Dr. Najat Khan, Chief Data Science Officer, Janssen Research & Development, Dr. Robert Califf, Head of Clinical Policy & Strategy, Verily & Google Health
    Moderator: Sastry Chilukuri, President, Acorn AI- Medidata

  • Rare Disease Panel

    Panelists: Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals, Dr. Frank Bennett, Chief Scientific Officer, Ionis Pharmaceuticals, Dr. John Orloff, Head of Research & Development, Alexion, Dr. Katherine High, President - Therapeutics, AskBio, Majid Jafar, Co-Founder, Loulou Foundation
    Moderator: Dr. Alfred Sandrock, Head of Research and Development, Biogen
     

  • Closing Remarks by Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals

14th Annual BioPharma & Healthcare Summit, September 4, 2020 - Virtual Edition
 
  • Welcome address by Karun Rishi, President, USAIC
  • Opening Address by Andrew Plump

    Opening comments Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals

  • COVID-19 panel- Where are we now? Where are we going?

    Panelists: Dr. Barry Bloom, Professor & former Dean, Harvard School of Public Health; Dr. George Yancopoulos, Co-Founder, President & CSO, Regeneron; Kiran Mazumdar-Shaw, Executive Chairperson, Biocon; Dr. Rajeev Venkayya, President of the Global Vaccine Business Unit, Takeda; Dr. Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)
    Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

  • India Regulatory Update

    Dr. Mandeep Bhandari, Joint Secretary, Ministry of Health & Family Welfare, India; Dr. V G Somani, Drug Controller General of India, Central Drug Control Organization
    Moderator: Muna Bhanji, Senior Vice President,  Merck & Co.

  • Fireside Chat with Kenneth Frazier moderated by Stelios Papadopoulos

    Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co.
    Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

  • India Innovation Landscape Panel

    Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India (NITI); Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group; Dr. K. Vijay Raghavan, Principal Scientific Advisor, Government of India; Dr. Naresh Trehan, Chairman, Medanta - the Medicity
    Moderator: Sanat Chattopadhyay, President, Merck Manufacturing Division; Merck & Co.

  • Oncology panel discussion: Changing landscape- COVID learnings and the promise of new technologies

    Panelists: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic; Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute; Dr. Philip Larsen, Global Head of Research, Bayer AG; Rehan Verjee, President, EMD Serono; Dr. Tony Ho, Head of Research and Development, CRISPR Therapeutics
    Moderator: Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School

  • Industry & Investment Outlook Panel Discussion

    Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital; Daphne Zohar, Founder & CEO, PureTech Health; Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University; Dr. Stelios Papadopoulos, Chairman, Biogen
    Moderator: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals

  • Rare Diseases panel: No longer forgotten; but more to be achieved

    Panelists: Dr. Alfred Sandrock, Executive Vice President, Research & Development, Biogen; Dr. Daniel Curran, Head of the Rare Diseases Therapeutic Area Unit, Takeda; Dr. David Meeker, Chairman & CEO , Rhythm Pharmaceuticals; Dr. John Orloff, Head of Research & Development, Alexion; Matt Wilsey, Co-Founder & Chairman, Grace Science Foundation
    Moderator: Dr. Steve Uden, Co-Founder, Rallybio

  • Fireside Chat with Roy Vagelos moderated by Mathai Mammen

    Dr. Roy Vagelos, Chairman of the Board, Regeneron Pharmaceuticals
    Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson

  • Digital & Data Science in Healthcare Panel: Pragmatic Insights from the Real-World

    Panelists: Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals; Arpa GarayPresident, Global Pharmaceuticals, Commercial Analytics, Merck & Co.; Dr. Maya Said, Chief Executive Officer, Outcomes4Me; Dr. Najat Khan, Chief Operating Officer, Janssen R&D Data Sciences, Johnson & Johnson; Nina Kjellson, General Partner, Canaan
    Moderator: Sastry Chilukuri, President, Acorn AI- Medidata

  • R&D Strategies and Trends Panel: Innovation- The Big I

    Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals; Dr. David Reese, Executive Vice President, Research and Development, Amgen; Dr. Hal Barron, Chief Scientific Officer and President R&D, GlaxoSmithKline; Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson
    Moderator: Dr. Martin Mackay, Co-Founder, Rallybio

  • Closing Remarks by Andrew Plump, President of R&D, Takeda
© 2007 - USA India Chamber of Commerce Home | About us | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | Legal | Contact us